BamSEC and AlphaSense Join Forces
Learn More

Aclaris Therapeutics Inc.

NASDAQ: ACRS    
Share price (1/8/25): $2.46    
Market cap (1/8/25): $176 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-Q 2 pages ​ Certificate of Amendment to Amended and Restated Certificate of Incorporation of Aclaris Therapeutics, Inc. ​
12/34/56
EX-3.1
from 8-K 25 pages Aclaris Therapeutics, Inc. Amended and Restated Bylaws ​ ​
12/34/56
EX-3.2
from 8-K 25 pages Amended and Restated Bylaws of Aclaris Therapeutics, Inc. (A Delaware Corporation) October 13, 2015 Aclaris Therapeutics, Inc. Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 5 pages Aclaris Therapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.5
from S-1/A 23 pages Amended and Restated Bylaws of Aclaris Therapeutics, Inc. (A Delaware Corporation) , 2015 Aclaris Therapeutics, Inc. Amended and Restated Bylaws
12/34/56
EX-3.3
from S-1/A 5 pages Aclaris Therapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.2
from S-1/A 3 pages Certificate of Amendment to Third Amended and Restated Certificate of Incorporation of Aclaris Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 17 pages Third Amended and Restated Certificate of Incorporation of Aclaris Therapeutics, Inc
12/34/56
EX-3.4
from S-1 17 pages Bylaws of Aclaris Therapeutics, Inc. (A Delaware Corporation) Adopted on July 13, 2012 Bylaws of Aclaris Therapeutics, Inc
12/34/56
EX-3.1
from S-1 17 pages Second Amended and Restated Certificate of Incorporation of Aclaris Therapeutics, Inc
12/34/56
EX-3.4
from DRS 17 pages Bylaws of Aclaris Therapeutics, Inc. (A Delaware Corporation) Adopted on July 13, 2012 Bylaws of Aclaris Therapeutics, Inc
12/34/56
EX-3.1
from DRS 17 pages Second Amended and Restated Certificate of Incorporation of Aclaris Therapeutics, Inc
12/34/56